Eksempler på bruk av Not be used in children på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Protopic ointment should not be used in children aged below 2 years until further data are available.
REYATAZ should not be used in children less than 3 months because of safety concerns especially taking into account the potential risk of kernicterus.
Noxafil concentrate for solution for infusion should not be used in children aged below 18 years because of pre-clinical safety concerns(see section 5.3).
Myfenax should not be used in children and adolescents(aged 2 to 18)
Avapro should not be used in children younger than 6 years old;
Constella should not be used in children and adolescents as it has not been studied in this population.
DIFICLIR should not be used in children or adolescents aged below 18 years as there is no information on this use in this population.
YERVOY should not be used in children and adolescents below 18 years of age until more information becomes available.
Medicines radiolabelled with Cuprymina should not be used in children and adolescents up to 18 years.
Moreover it should not be used in children younger than 2 years of age because of safety concerns.
Oprymea should not be used in children or adolescents with Tourette Disorder because of a negative benefit-risk balance for this disorder see section 5.1.
PhotoBarr should not be used in children and adolescents below 18 years of age, due to lack of experience.
Pramipexole Accord should not be used in children or adolescents with Tourette Disorder because of a negative benefit-risk balance for this disorder see section 5.1.
Rasilez HCT must not be used in children from birth to less than 2 years of age.
Selincro should not be used in children or adolescents below the age of 18 years because Selincro has not been tested in this age group.
Stribild should not be used in children aged 0 to less than 6 years because of safety/efficacy concerns.
Therefore, Rasilamlo is contraindicated in children from birth to less than 2 years and should not be used in children aged 2 to less than 6 years.
Therefore, Rasilez HCT is contraindicated in children from birth to less than 2 years and should not be used in children aged 2 to less than 6 years.
Actinic keratosis does not occur in children, and this medicine must not be used in children and adolescents under 18 years of age.